TickerFacts.

Ovid Therapeutics Inc. (OVID): Revenue

Annual figures by period end, from SEC filings.

$7.25M
Year ended 2025-12-31
$1.58M
Trailing 12 months to 2026-06-30
+69.0%
3-year compound annual growth
-10.5%
5-year compound annual growth
$208.38M2020-12-31: $12.62M2021-12-31: $208.38M2022-12-31: $1.50M2023-12-31: $392.0K2024-12-31: $566.0K2025-12-31: $7.25M$7.25M
2020-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$7.25Mn/m2026-03-18, From 2025-01-01
2024-12-31$566.0K+44.4%2026-03-18, From 2024-01-01
2023-12-31$392.0K-73.9%2025-03-11, From 2023-01-01
2022-12-31$1.50M-99.3%2024-03-08, From 2022-01-01
2021-12-31$208.38Mn/m2023-03-13, From 2021-01-01
2020-12-31$12.62Mn/a2022-03-15, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Ovid Therapeutics Inc. (OVID)2025-12-31$7.25Mn/m
Whitehawk Therapeutics, Inc. (WHWK)2025-12-31$7.14M-72.5%
Xenon Pharmaceuticals Inc. (XENE)2025-12-31$7.50Mn/a
Immunome Inc. (IMNM)2025-12-31$6.94M-23.2%
Adagene Inc. (ADAG)2025-12-31$7.67Mn/m
Bolt Biotherapeutics, Inc. (BOLT)2025-12-31$7.70M+0.1%
Aclaris Therapeutics, Inc. (ACRS)2025-12-31$7.83M-58.2%
Coya Therapeutics, Inc. (COYA)2025-12-31$7.95M+123.6%
Korro Bio, Inc. (KRRO)2025-12-31$6.39M+181.5%

Compare OVID, WHWK, XENE, IMNM side by side · Screen every company in Pharmaceutical Preparations ↗